These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23702081)

  • 21. A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions?
    van Zimmeren E; Verbeure B; Matthijs G; Van Overwalle G
    Bull World Health Organ; 2006 May; 84(5):352-9. PubMed ID: 16710543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.
    Berthels N; Matthijs G; Van Overwalle G
    Eur J Hum Genet; 2011 Nov; 19(11):1114-21. PubMed ID: 21811306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of gene patents and licensing practices on access to genetic testing for hearing loss.
    Chandrasekharan S; Fiffer M
    Genet Med; 2010 Apr; 12(4 Suppl):S171-93. PubMed ID: 20393307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [From intellectual property to commercial property].
    Cappelaere P
    Bull Cancer; 2005 Apr; 92(4):297-8. PubMed ID: 15888384
    [No Abstract]   [Full Text] [Related]  

  • 25. Actor-network theory: a tool to support ethical analysis of commercial genetic testing.
    Williams-Jones B; Graham JE
    New Genet Soc; 2003 Dec; 22(3):271-96. PubMed ID: 15115034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
    Chandrasekharan S; Heaney C; James T; Conover C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S194-211. PubMed ID: 20393308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies.
    Pierce BL; Carlson CS; Kuszler PC; Stanford JL; Austin MA
    Genet Med; 2009 Mar; 11(3):202-9. PubMed ID: 19367193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Social contract theory and just decision making: lessons from genetic testing for the BRCA mutations.
    Williams-Jones B; Burgess MM
    Kennedy Inst Ethics J; 2004 Jun; 14(2):115-42. PubMed ID: 15281186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA as patentable subject matter and a narrow framework for addressing the perceived problems caused by gene patents.
    Schilling SH
    Duke Law J; 2011 Dec; 61(3):731-73. PubMed ID: 22165443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patent first, ask questions later: morality and biotechnology in patent law.
    Bagley MA
    William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.
    Merz JF
    Clin Chem; 1999 Mar; 45(3):324-30. PubMed ID: 10053032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent prosecution strategies for stem cell related applications.
    Kumar R; Yeh JJ; Fernandez D; Hansen N
    J Biomol Screen; 2007 Sep; 12(6):769-74. PubMed ID: 17848639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patents and human rights: a heterodox analysis.
    Gold ER
    J Law Med Ethics; 2013; 41(1):185-98. PubMed ID: 23581665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 35. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fate and future of patents on human genes and genetic diagnostic methods.
    Huys I; Matthijs G; Van Overwalle G
    Nat Rev Genet; 2012 May; 13(6):441-8. PubMed ID: 22596320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
    Rai AK
    Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can International Patent Law Help Mitigate Cancer Inequity in LMICs?
    Ragavan S; Vanni A
    AMA J Ethics; 2020 Feb; 22(2):E102-111. PubMed ID: 32048580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic patent singles out Jewish women.
    Abbott A
    Nature; 2005 Jul; 436(7047):12. PubMed ID: 16001030
    [No Abstract]   [Full Text] [Related]  

  • 40. Gene patents, health care policy and licensing schemes.
    Caulfield T; von Tigerstrom B
    Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.